Skip to main content

Table 1 Demographics of patients with systemic sclerosis (SSc), and medications being taken

From: Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

 

With diffuse SSca (n = 23)

With limited SSca (n = 19)

Age (y) [mean ± SEM]

42.5 ± 2.8

46.5 ± 2.9

% female

95.7

100

Disease duration (mo.) [mean ± SEM]

72.7 ± 15.7

95.4 ± 17.1

Medications (% of sample)

   Prednisone

82.6

68.4

   D-penicillamine

69.6

57.9

   Cyclophosphamide

17.4

5.3

  1. aP ≥ 0.05 in a comparison of the two groups (Mann–Whitney rank sum test). SEM, standard error of the mean.